{"filing":{"accession_number":"0001628280-26-061445","cik":"0001411685","ticker":"VTGN","company_name":"Vistagen Therapeutics, Inc.","form":"8-K","filing_date":"2026-09-10","report_date":"2026-09-10","primary_document":"vtgn-20260910.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/vtgn-20260910.htm"},"events":[{"id":32773,"run_id":30132,"accession_number":"0001628280-26-061445","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of Vistagen's 2026 Annual Meeting of Stockholders held on September 10, 2026, including voting outcomes on three proposals: (i) election of four directors by plurality vote, (ii) non-binding advisory approval of named executive officer compensation, and (iii) ratification of KPMG LLP as independent auditors. The filing presents vote tallies for each proposal, confirming all three passed. This is a classic shareholder vote results disclosure material to investors' understanding of governance and board composition.","company_name":"Vistagen Therapeutics, Inc.","ticker":"VTGN","filing_date":"2026-09-10","form":"8-K","submitted_at":null,"items":[{"id":36032,"accession_number":"0001628280-26-061445","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Vistagen's 2026 Annual Meeting of Stockholders held on September 10, 2026, including voting outcomes on three proposals: (i) election of four directors by plurality vote, (ii) non-binding advisory approval of named executive officer compensation, and (iii) ratification of KPMG LLP as independent auditors. The filing presents vote tallies for each proposal, confirming all three passed. This is a classic shareholder vote results disclosure material to investors' understanding of governance and board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T10:04:08.294826+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36032,"accession_number":"0001628280-26-061445","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Vistagen's 2026 Annual Meeting of Stockholders held on September 10, 2026, including voting outcomes on three proposals: (i) election of four directors by plurality vote, (ii) non-binding advisory approval of named executive officer compensation, and (iii) ratification of KPMG LLP as independent auditors. The filing presents vote tallies for each proposal, confirming all three passed. This is a classic shareholder vote results disclosure material to investors' understanding of governance and board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T10:04:08.294826+00:00","company_name":"Vistagen Therapeutics, Inc.","ticker":"VTGN","filing_date":"2026-09-10"}]}